https://www.theguardian.com/world/2020/oct/22/uk-g

New Post Public Reply Private Reply Replies (2) Message Board
Crunch55
434
https://www.theguardian.com/world/2020/oct/22...2000-a-day


Subscribe
The Guardian - Back to home
News
Opinion
Sport
Culture
Lifestyle

Job ad
Show caption
Coronavirus
UK government seeks test and trace executive for up to £2,000 a day
Health department has since taken advertisement down, saying it needs to be redrafted

Coronavirus – latest updates
See all our coronavirus coverage
Amy Walker
Thu 22 Oct 2020 20.27 BST
Share on FacebookShare on TwitterShare via Email
The government is seeking a director of operations for its beleaguered test-and-trace system who can turn around “ failing call centres ” for a rate of up to £2,000 a day.

A job advert posted on recruitment sites stated that the Department of Health and Social Care (DHSC) was looking for a temporary “VP of operations” with experience “in running call centres of 18,000”.


It comes as the prime minister, Boris Johnson, admitted that the £12bn coronavirus contact-tracing service needed to provide faster results and he shared “people’s frustrations” over turnaround times. Figures published on Thursday showed test and trace figures had hit a new low of less than 60% of close contacts being reached, while turnaround times had risen to nearly 48 hours.

The job post added that the DHSC was looking for a candidate who “can implement improvements straight away”, had “experience (and evidence) of turning around failing call centres” and had “examples of quick wins”.

The advert, which was posted on the website of the recruitment company Quast, has since been taken down. An employee at Quast confirmed that the job advert had been placed with them, adding that they had only realised the “nature and sensitivity of the role” once they began to get inquiries about the job.

The deadline for applications was listed as Friday 23 October.

The DHSC confirmed that it was actively recruiting for the role, but added that the advert would be redrafted. It did not deny or confirm whether the day rate for a successful applicant would be up to £2,000 a day, as originally stated.

A DHSC spokesperson said: “The text for this advert was not drafted or approved by the department. As part of our ongoing commitment to improve services, we are recruiting experienced employees with a wide range of experience, including driving high performance.

“To date, with the help of NHS test and trace call handlers, the service has contacted over 1 million people who may have been at risk of unwittingly spreading the virus.”

Speaking during a Downing Street coronavirus briefing on Thursday, Johnson said the system, designed to contain outbreaks by ensuring that anyone exposed to virus self-isolates, was helping “a bit”.

“The thing depends on people self-isolating and breaking the transmission. It is helping a bit already to break the transmission. About 1 million contacts have been reached. But there is more that it can do if everybody complies once they are contracted by NHS test and trace.”


Alongside him, Sir Patrick Vallance said the “diminishing” effectiveness of test and trace was in part inevitable as coronavirus cases rose in the second wave – but also a result of the system’s operation.

Figures published by the government showed that in the week ending 14 October, 59.6% of close contacts were reached, down from the previous week’s figure of 62.6%, which was the lowest since the test-and-trace operation was launched at the end of May.

Since you’re here...
… we’re asking readers like you to support our open, independent journalism. Millions are flocking to the Guardian for high-quality news every day, and readers in 180 countries around the world now support us financially – this makes our work possible.

We believe every one of us deserves equal access to factual information and analysis that has authority and integrity. So, unlike many others, we keep Guardian journalism open for all, regardless of where they live or what they can afford to pay.

The Guardian’s independence means we investigate, interrogate and expose the actions of those in power, without fear. Our journalism is free from commercial and political bias – never influenced by billionaire owners or shareholders. This makes us different. We can give a voice to the oppressed and neglected, and stand in solidarity with those who are calling for a fairer future.

.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading